Literature DB >> 21863342

The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells.

Anna Rose1, Emily Kay, Brendan W Wren, Margaret J Dallman.   

Abstract

Campylobacter jejuni is the leading cause of human bacterial gastroenteritis worldwide, mainly caused by handling and consumption of contaminated poultry. However, the immune response to infection is poorly understood. Here, the impact of the C. jejuni capsule, flagella and the N-linked glycosylation system on cytokine production by dendritic cells was investigated. Bone marrow-derived murine dendritic cells (BMDCs) infected with C. jejuni lacking the N-linked glycosylation system produced similar amounts of cytokines compared to cells infected with C. jejuni 11168H wild-type (WT) cultures. C. jejuni flagellin FlaA mutants elicited reduced IL-6 and IL-10 production in BMDCs compared to C. jejuni WT and this reduction was more pronounced in TLR4(-/-) BMDCs. An acapsular C. jejuni mutant as well as a mutant lacking the O-methyl phosphoramidate modification of the capsule elicited a higher cytokine response in BMDCs. Experiments with TLR4(-/-) BMDCs revealed that this increased cytokine production was not solely dependent on signalling through TLR4. Therefore, the C. jejuni capsule is important to prevent excessive cytokine production by BMDCs and even minor changes in capsule composition such as the lack of the O-methyl phosphoramidate modification can lead to increased cytokine production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863342     DOI: 10.1007/s00430-011-0214-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  36 in total

1.  Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance.

Authors:  Andries van Mourik; Liana Steeghs; Jacoline van Laar; Hugo D Meiring; Hendrik-Jan Hamstra; Jos P M van Putten; Marc M S M Wösten
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

2.  Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity.

Authors:  A V Karlyshev; D Linton; N A Gregson; A J Lastovica; B W Wren
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

3.  Knockout mutagenesis of the kpsE gene of Campylobacter jejuni 81116 and its involvement in bacterium-host interactions.

Authors:  Boy M Bachtiar; Peter J Coloe; Benjamin N Fry
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02

4.  Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium.

Authors:  Priscilla A Johanesen; Michael B Dwinell
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Innate immune gene expression differentiates the early avian intestinal response between Salmonella and Campylobacter.

Authors:  Ronan G Shaughnessy; Kieran G Meade; Sarah Cahalane; Brenda Allan; Carla Reiman; John J Callanan; Cliona O'Farrelly
Journal:  Vet Immunol Immunopathol       Date:  2009-06-21       Impact factor: 2.046

6.  The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168.

Authors:  Frank St Michael; Christine M Szymanski; Jianjun Li; Kenneth H Chan; Nam Huan Khieu; Suzon Larocque; Warren W Wakarchuk; Jean-Robert Brisson; Mario A Monteiro
Journal:  Eur J Biochem       Date:  2002-11

7.  Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni.

Authors:  Vijay A K Rathinam; Kathleen A Hoag; Linda S Mansfield
Journal:  Microbes Infect       Date:  2008-08-05       Impact factor: 2.700

8.  Activation of human and chicken toll-like receptors by Campylobacter spp.

Authors:  Marcel R de Zoete; A Marijke Keestra; Paula Roszczenko; Jos P M van Putten
Journal:  Infect Immun       Date:  2009-12-28       Impact factor: 3.441

9.  Development and application of an insertional system for gene delivery and expression in Campylobacter jejuni.

Authors:  A V Karlyshev; B W Wren
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  15 in total

1.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 2.  Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.

Authors:  Amanda E Schnee; William A Petri
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.

Authors:  Renee M Laird; Zuchao Ma; Nelum Dorabawila; Brittany Pequegnat; Eman Omari; Yang Liu; Alexander C Maue; Steven T Poole; Milton Maciel; Kavyashree Satish; Christina L Gariepy; Nina M Schumack; Annette L McVeigh; Frédéric Poly; Cheryl P Ewing; Michael G Prouty; Mario A Monteiro; Stephen J Savarino; Patricia Guerry
Journal:  Vaccine       Date:  2018-09-27       Impact factor: 3.641

Review 5.  How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis.

Authors:  Christine M Szymanski; Erin C Gaynor
Journal:  Gut Microbes       Date:  2012-03-01

6.  Phase-Variable Changes in the Position of O-Methyl Phosphoramidate Modifications on the Polysaccharide Capsule of Campylobacter jejuni Modulate Serum Resistance.

Authors:  Brittany Pequegnat; Renee M Laird; Cheryl P Ewing; Christina L Hill; Eman Omari; Frederic Poly; Mario A Monteiro; Patricia Guerry
Journal:  J Bacteriol       Date:  2017-06-27       Impact factor: 3.490

7.  Key Role of Capsular Polysaccharide in the Induction of Systemic Infection and Abortion by Hypervirulent Campylobacter jejuni.

Authors:  Orhan Sahin; Samantha A Terhorst; Eric R Burrough; Zhangqi Shen; Zuowei Wu; Lei Dai; Yizhi Tang; Paul J Plummer; Ju Ji; Michael J Yaeger; Qijing Zhang
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

8.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

Review 9.  The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease.

Authors:  Sean M Callahan; Carolina G Dolislager; Jeremiah G Johnson
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 10.  Campylobacter polysaccharide capsules: virulence and vaccines.

Authors:  Patricia Guerry; Frédéric Poly; Mark Riddle; Alexander C Maue; Yu-Han Chen; Mario A Monteiro
Journal:  Front Cell Infect Microbiol       Date:  2012-02-15       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.